Related Experiment Videos
Adverse effects of clozapine
R Grohmann1, E Rüther, N Sassim
1Psychiatric Department, Munich University, Federal Republic of Germany.
Psychopharmacology
|January 1, 1989
Summary
Clozapine use in psychiatric inpatients led to adverse drug reactions (ADRs) in 76% of cases, with severe reactions in 3.9%. Careful monitoring is crucial for clozapine safety.
Area of Science:
- Pharmacovigilance
- Psychiatry
- Clinical Pharmacology
Background:
- Assessing adverse drug reactions (ADRs) of clozapine in a post-marketing surveillance program (AMUP study).
- Focus on two university psychiatric departments for intensive drug monitoring.
Observation:
- 76% of clozapine-treated inpatients experienced ADRs.
- Common ADRs included sedation, hypersalivation, elevated transaminases, and EEG changes.
- Severe ADRs occurred in 3.9% of patients, with toxic delirium being prevalent.
Findings:
- ADRs rarely necessitated therapy changes, but 8.1% of patients discontinued clozapine due to ADRs.
- Severe cardiovascular and respiratory dysregulation observed with clozapine-benzodiazepine combination.
- One case of sudden death noted with clozapine-haloperidol treatment.
Implications:
- Highlights the importance of vigilant monitoring for clozapine-related adverse events.
- Suggests caution when co-administering clozapine with benzodiazepines or haloperidol.
- Provides comparative data on clozapine's safety profile versus other neuroleptics.